MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene

Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer

(2016) Xi Gu et al.   Cancer Biomarkers

MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene

(2016) Youguang Pu et al.   Cancer Cell International

Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma

(2016) Shuying Zhu et al.   MEDICAL SCIENCE MONITOR

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy

(2015) E Lau et al.   ONCOGENE

Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line

(2015) Xi Gu et al.   MEDICAL SCIENCE MONITOR

MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients

(2015) Kai Doberstein et al.   NEOPLASIA

ATF2: A transcription factor that elicits oncogenic or tumor suppressor activities

(2014) Anindita Bhoumik et al.   CELL CYCLE

MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc

(2014) Dongqin Chen et al.   EUROPEAN JOURNAL OF CANCER

ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway

(2014) Marco Lo Iacono et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of the Tumor Suppressive miRNA-23b/27b Cluster is a Good Prognostic Marker in Clear Cell Renal Cell Carcinoma

(2014) Tomoaki Ishihara et al.   JOURNAL OF UROLOGY

MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN

(2013) Fang Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β

(2013) He-Ping Li et al.   CARCINOGENESIS

MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors

(2013) Caroline M.M. Gits et al.   INTERNATIONAL JOURNAL OF CANCER

Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients

(2013) Ana L. Teixeira et al.   TUMOR BIOLOGY

Tumor-suppressivemicroRNA-135ainhibits cancer cell proliferation by targeting thec-MYConcogene in renal cell carcinoma

(2012) Yasutoshi Yamada et al.   CANCER SCIENCE

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

(2012) Martina Redova et al.   Journal of Translational Medicine

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN

(2012) Zhi-Li Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients

(2011) Jianning Song et al.   DIGESTIVE DISEASES AND SCIENCES

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)

(2011) Hai-Bo Bian et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues

(2009) Zhengjun Yi et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c

(2008) C Nakada et al.   JOURNAL OF PATHOLOGY